Lorlatinib: Tablet 25 mg, Tablet 100 mg; Lorviqua® Page last updated: 1 April 2022 Public Summary Document (PSD) December 2021 PBAC Meeting - (PDF 609KB) Public Summary Document (PSD) December 2021 PBAC Meeting - (Word 88KB)